Case number IPR2018-01119
Mylan Technologies, Inc. v. Noven Pharmaceuticals, Inc. > Documents
| Date Field | Doc. No. | Party | Description |
|---|---|---|---|
| Nov 16, 2018 | 14 | Notice of Refund Download | |
| Oct 26, 2018 | 13 | Petitioner's Request for Refund Download | |
| Sep 28, 2018 | 12 | Granting Joint Motion to Expunge 37 C.F.R. sec 42.5 Download | |
| Sep 26, 2018 | 11 | Joint Motion to Expunge Exhibit 2025 Under 37 C.F.R. Section 42.56 Download | |
| Sep 10, 2018 | 10 | Decision Granting Joint Motion to Terminate Due to Settlement Prior to Institution Download | |
| Sep 5, 2018 | 9 | Patent Owner's Updated Exhibit List as of September 5, 2018 Download | |
| Sep 5, 2018 | 7 | Joint Motion to Terminate Proceedings Download | |
| Sep 5, 2018 | 8 | Joint Request to Treat Binding Term Sheet (EX2025) as Business Confidential Information Download | |
| Aug 22, 2018 | 2016 | U.S. Patent No. 8,029,820 Download | |
| Aug 22, 2018 | 2011 | A. Williams & B. Barry, Chemical Permeation Enhancement, in ENHANCEMENT IN DRUG DELIVERY 233, 248-50 (E. Touitou & B. Barry eds., 2007) Download | |
| Aug 22, 2018 | 2002 | Curriculum Vitae of Dr. Adrian C. Williams Download | |
| Aug 22, 2018 | 2024 | Comparison of Claims 1-15 of U.S. 9,833,419 and U.S. 9,724,310 Download | |
| Aug 22, 2018 | 2001 | Declaration of Dr. Adrian C. Williams Download | |
| Aug 22, 2018 | 2019 | J. Bond & B. Barry, Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin, 90(6) J. INVEST. DERMATOL. 810-813 (1988) Download | |
| Aug 22, 2018 | 2021 | R. Subedi et al., Formulation and in vitro evaluation of transdermal drug delivery system for donezil, 42 J. PHARMA. INVEST. 1-7 (2012) Download | |
| Aug 22, 2018 | 2017 | B. Godin & E. Touitou, Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models, 59(11) ADV. DRUG DELIV. REVIEWS 1152-1161 (2007) Download | |
| Aug 22, 2018 | 2005 | J. Hadgraft, Passive enhancement strategies in topical and transdermal drug delivery, 184 INT'L J. PHARMACEUTICS 1-6 (1999) Download | |
| Aug 22, 2018 | 2008 | K. Brain & R. Chilcott, Physicochemical Factors Affecting Skin Absorption, in PRINCIPLES AND PRACTICE OF SKIN TOXICOLOGY 83-92 (R. Chilcott and S. Price eds., 2008) Download | |
| Aug 22, 2018 | 2023 | J. van de Sandt et al., In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study, 39 REG. TOXICOL. PHARMACOL. 271¿¿¿281 (2004) Download | |
| Aug 22, 2018 | 2018 | R. Hinz et al., In vitro percutaneous penetration: evaluation of the utility of hairless mouse skin, 93(1) J. INVEST. DERMATOL. 87-91 (1989) Download | |
| Aug 22, 2018 | 2003 | Minivelle¿¿ Product Label Download | |
| Aug 22, 2018 | 2007 | A. Williams & B. Barry, Urea analogues in propylene glycol as penetration enhancers in human skin, 36 INT'L J. PHARMACEUTICS 43-50 (1989) Download | |
| Aug 22, 2018 | 2020 | R. Subedi et al., Influence of formulation variable in transdermal drug delivery system containing zolmitriptan, 419 INT'L J. PHARMACEUTICS 209-214 (2011) Download | |
| Aug 22, 2018 | 2009 | Esclim Product Label Download | |
| Aug 22, 2018 | 2015 | A. Ghosh et al., Current Pharmaceutical Design on Adhesive Based Transdermal Drug Delivery Systems, 21 CURR. PHARM. DESIGN 2771-2783 (2015) Download | |
| Aug 22, 2018 | 2006 | B. Barry, Transdermal Drug Delivery, in AULTON'S PHARMACEUTICS ¿¿¿ THE DESIGN AND MANUFACTURE OF MEDICINES 565, 571-72, 577 (M. Aulton ed., 3d ed. 2007) Download | |
| Aug 22, 2018 | 2012 | A. Williams & B. Barry, The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs, 74 INT'L J. PHARMACEUTICS 157-168 (1991) Download | |
| Aug 22, 2018 | 2004 | J. Hadgraft and R. Guy, Feasibility Assessment in Topical and Transdermal Delivery, in TRANSDERMAL DRUG DELIVERY 3-4 (R. Guy & J. Hadgraft eds., 2d ed. 2003) Download | |
| Aug 22, 2018 | 2014 | Google Scholar search results obtained March 7, 2018 ¿¿¿ citations of Kim et al., Penetration Enhancement of ¿¿2-Selective Agonist, Tulobuterol, Across Hairless Mouse Skin, J. Pharm. Invest. 33: 79-84 (2003) Download | |
| Aug 22, 2018 | 6 | Patent Owner Preliminary Response Download | |
| Aug 22, 2018 | 2013 | K. Walters & K. Brain, Dermatological Formulation and Transdermal Systems, in DERMATOLOGICAL AND TRANSDERMAL FORMULATIONS 338-43 (K. Walters, ed., 2002) Download | |
| Jun 28, 2018 | 5 | Noven Pharmaceuticals, Inc.'s First Updated Mandatory Notice Under 37 C.F.R. Section 42.8 Download | |
| Jun 7, 2018 | 4 | Patent Owner Mandatory Notices Download | |
| May 23, 2018 | 3 | Notice of Accord Filing Date Download | |
| May 18, 2018 | 1016 | EX1016 Alora - Document #5210490A Download | |
| May 18, 2018 | 1022 | EX1022 Bucks Download | |
| May 18, 2018 | 1025 | EX1025 van der Bijl Download | |
| May 18, 2018 | 1004 | EX1004 U.S. 9,833,419 File History Download | |
| May 18, 2018 | 1040 | EX1040 Mantelle Download | |
| May 18, 2018 | 1015 | EX1015 Climara - Document #5243107A Download | |
| May 18, 2018 | 1002 | EX1002 Brain Declaration Download | |
| May 18, 2018 | 1035 | EX1035 US 9,730,900 File History Part 1 of 2 Download | |
| May 18, 2018 | 1038 | EX1038 US 9,724,310 File History Part 1 of 2 Download | |
| May 18, 2018 | 1038 | EX1038 US 9,724,310 File History Part 1 of 2 Download | |
| May 18, 2018 | 1 | Petitioner's Power of Attorney Download | |
| May 18, 2018 | 1018 | EX1018 US Patent No. 5,902,602 to Muller Download | |
| May 18, 2018 | 1010 | EX1010 Kim Download | |
| May 18, 2018 | 1039 | EX1039 Benson Download | |
| May 18, 2018 | 1024 | EX1024 Butschhli - Tiny Patch 'Dots' Pharmaceutical Landscape Download | |
| May 18, 2018 | 1009 | EX1009 US Patent No. 5,145,682 to Chien Download | |
| May 18, 2018 | 1013 | EX1013 US Patent No. 5,919,477 to Bevan Download | |
| May 18, 2018 | 1001 | EX1001 U.S. Patent No. 9,833,419 to Mantelle Download | |
| May 18, 2018 | 1019 | EX1019 US Patent No. 6,156,335 to Rovati Download | |
| May 18, 2018 | 1021 | EX1021 US Patent No. 5,227,169 to Heiber Download | |
| May 18, 2018 | 1033 | EX1033 US Patent No. 6,024,976 to Miranda Download | |
| May 18, 2018 | 1041 | EX1041 Mantelle Download | |
| May 18, 2018 | 1012 | EX1012 WO 1996003119 to Fotinos Download | |
| May 18, 2018 | 1003 | EX1003 Brain CV Download | |
| May 18, 2018 | 1023 | EX1023 Dinger - Noven Pharmaceuticals, Inc Download | |
| May 18, 2018 | 1020 | EX1020 US Patent No. 6,521,250 to Meconi Download | |
| May 18, 2018 | 1037 | EX1037 US 9,724,310 to Mantelle Download | |
| May 18, 2018 | 2 | Petition for Inter Partes Review of US 9,833,419 Download | |
| May 18, 2018 | 1027 | EX1027 US Patent No. 5,352,457 to Jenkins Download | |
| May 18, 2018 | 1030 | EX1030 US Patent No. 6,638,528 to Kanios Download | |
| May 18, 2018 | 1035 | EX1035 US 9,730,900 File History Part 1 of 2 Download | |
| May 18, 2018 | 1042 | EX1042 DE10012908 Download | |
| May 18, 2018 | 1007 | EX1007 US Pat Pub 20060078602 to Kanios Download | |
| May 18, 2018 | 1008 | EX1008 Vivelle Label FOI Affidavit and Doc 5210567A Download | |
| May 18, 2018 | 1014 | EX1014 Ghosh Download | |
| May 18, 2018 | 1028 | EX1028 US Patent No. 5,603,947 to Wong Download | |
| May 18, 2018 | 1026 | EX1026 Bronaugh Download | |
| May 18, 2018 | 1011 | EX1011 US Patnt No. 5,656,286 to Miranda Download | |
| May 18, 2018 | 1017 | EX1017 Menostar - Document #5228320A Download | |
| May 18, 2018 | 1006 | EX1006 Vivelle-Dot Label FOI Affidavit and Doc 5236149B Download | |
| May 18, 2018 | 1034 | EX1034 The Orange Book Download | |
| May 18, 2018 | 1031 | EX1031 US Patent No. 4,624,665 to Nuwayser Download | |
| May 18, 2018 | 1005 | EX1005 US Pat Pub 20030099695 to Mueller Download | |
| May 18, 2018 | 1035 | EX1035 US 9,730,900 File History Part 2 of 2 Download | |
| May 18, 2018 | 1038 | EX1038 US 9,724,310 File History Part 2 of 2 Download |
